MUC16 and neoplasm: Cognate chemokine receptors were subsequently co-expressed in second generation CD28-costimulated CAR-T cells targeting the retained portion of the tumor associated antigen Muc16/CA125 (4H11) and evaluated for tumor-directed trafficking in vitro and in vivo.